M&A Deal Summary

Astex Pharmaceuticals Acquires Montigen Pharmaceuticals

On April 4, 2006, Astex Pharmaceuticals acquired life science company Montigen Pharmaceuticals

Acquisition Highlights
  • This is Astex Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Astex Pharmaceuticals’ 1st transaction in the United States.
  • This is Astex Pharmaceuticals’ 1st transaction in Utah.

M&A Deal Summary
Date 2006-04-04
Target Montigen Pharmaceuticals
Sector Life Science
Buyer(s) Astex Pharmaceuticals
Deal Type Add-on Acquisition

Target

Montigen Pharmaceuticals

Salt Lake City, Utah, United States
Montigen Pharmaceuticals, Inc. is an oncology focused drug discovery and development company.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Astex Pharmaceuticals

Dublin, California, United States
Category Company
Founded 1991
Sector Life Science
Employees136
DESCRIPTION

Astex Pharmaceuticals, Inc. is a provider of drug discovery, development and commercialization, committed to the fight against cancer and other life threatening diseases.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2006) 1 of 1
Mergr

Product

Company

Legal